Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gossamer Bio Inc (NQ: GOSS )

0.6695 -0.0138 (-2.02%)
Streaming Delayed Price Updated: 2:59 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Gossamer Bio Inc

< Previous 1 2 Next >
Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Addition of Two CNS-Penetrant BTK Inhibitors to its Product Candidate Pipeline: GB5121 & GB7208
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces GB004 Clinical Trial Data Presentations at 2021 Virtual Congress of the European Crohn’s and Colitis Organisation
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
From Gossamer Bio
Via Business Wire
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific Officer
From Gossamer Bio, Inc.
Via Business Wire
Gossamer Bio Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs
From Gossamer Bio, Inc.
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.